LTFS
KIN

Ladenburg Thalmann Financial Services’s Kindred Biosciences, Inc. KIN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$8K Hold
1,000
– – ﹤0.01% 4608
2019
Q3 		$7K Hold
1,000
– – ﹤0.01% 4575
2019
Q2 		$8K Hold
1,000
– – ﹤0.01% 4560
2019
Q1 		$9K Buy
+1,000
New +$10.2K ﹤0.01% 4447

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Ladenburg Thalmann Financial Services's KIN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Kindred Biosciences, Inc. (KIN) position steady in Q4 2019 at 1,000 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4608.

Ladenburg Thalmann Financial Services first reported a position in KIN in Q1 2019 and has held it in 4 quarters since. The position peaked at $9K in Q1 2019. 75 funds tracked by Wall St. Rank hold KIN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,000 shares of Kindred Biosciences, Inc. worth $8K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Kindred Biosciences, Inc. share count unchanged in Q4 2019.
  • Kindred Biosciences, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4608 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Kindred Biosciences, Inc. in Q1 2019 and has held it in 4 quarters since.
  • Ladenburg Thalmann Financial Services's Kindred Biosciences, Inc. position peaked at $9K in Q1 2019.
  • 75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.